Biological Information
Background Information:
N-Terminal FLAG-tagged, recombinant, full length human mTOR. mTOR (Mechanistic Target Of Rapamycin Kinase) belongs to the family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This kinase is a component of two distinct complexes, mTORC1, which controls protein synthesis, cell growth and proliferation, and mTORC2, which is a regulator of the actin cytoskeleton, and promotes cell survival and cell cycle progression. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. Inhibitors of mTOR are used in organ transplants as immunosuppressants, and are being evaluated for their therapeutic potential in SARS-CoV-2 infections.
Target Class:
Kinase
Family:
Phosphatidylinositol-3 kinase-related kinase (PIKK)
Sub Family:
Serine/threonine kinase (atypical)
Protein Name:
mTOR
Protein Aliases:
serine/threonine-protein kinase mTOR
Accession Number:
GenBank NM_004958.2
UniProt Number:
P42345
Gene Name:
MTOR
Gene ID:
2475
Gene Aliases:
SKS; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
12 months at -70°C
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Enzymatic
Clinical Relevance
Therapeutic Area:
Oncology